# Differential association of CD68+ and CD163+ macrophages with macrophage enzymes, whole tumour gene expression and overall survival in advanced melanoma

**Authors:** Liam Friel Tremble, Mark McCabe, Sidney P. Walker, Siobhán McCarthy, Réiltín F. Tynan, Suzanne Beecher, Réiltín Werner, A. James P. Clover, X. Derek G. Power, Patrick F. Forde, Cynthia C. B. B. Heffron

PMC · DOI: 10.1038/s41416-020-01037-7 · British Journal of Cancer · 2020-08-26

## TL;DR

This study explores how different types of macrophages in melanoma tumors affect gene expression and patient survival.

## Contribution

The study identifies distinct functional differences between CD68+ and CD163+ macrophages in melanoma.

## Key findings

- CD68+ macrophages are linked to increased iNOS and arginase activity and altered gene expression.
- CD163+ macrophages accumulate in larger tumors but show no functional activity or gene expression changes.
- Neither macrophage subset correlates with overall patient survival.

## Abstract

The density and phenotype of tumour-associated macrophages have been linked with prognosis in a range of solid tumours. While there is strong preclinical evidence that tumour-associated macrophages promote aspects of tumour progression, it can be challenging to infer clinical activity from surface markers and ex vivo behaviour. We investigated the association of macrophage infiltration with prognosis and functional changes in the tumour microenvironment in primary human melanoma.

Fifty-seven formalin-fixed, paraffin-embedded primary melanomas were analysed by immunohistochemical analysis of CD68, CD163, inducible nitric oxide synthase (iNOS) and arginase expression. RNA sequencing was performed on serial sections of 20 of the stained tumours to determine the influence of macrophage infiltration on gene expression.

CD68+ cells are a functionally active subset of macrophages that are associated with increased iNOS and arginase staining and altered gene expression. In comparison, while there is a greater accumulation of CD163+ macrophages in larger tumours, these cells are comparatively inactive, with no association with the level of iNOS or arginase staining, and no effect on gene expression within the tumour. The infiltration of either subset of macrophages did not correlate to overall survival.

Thus, melanomas contain distinct macrophage populations with diverse phenotypes, but with no observable prognostic role.

## Linked entities

- **Genes:** CD68 (CD68 molecule) [NCBI Gene 968], CD163 (CD163 molecule) [NCBI Gene 9332], NOS2 (nitric oxide synthase 2) [NCBI Gene 4843], LOC9310574 (arginase 1, mitochondrial) [NCBI Gene 9310574]
- **Diseases:** melanoma (MONDO:0005105)

## Full-text entities

- **Genes:** CDKN3 (cyclin dependent kinase inhibitor 3) [NCBI Gene 1033] {aka CDI1, CIP2, KAP, KAP1}, BIRC5 (baculoviral IAP repeat containing 5) [NCBI Gene 332] {aka API4, EPR-1}, BRAF (B-Raf proto-oncogene, serine/threonine kinase) [NCBI Gene 673] {aka B-RAF1, B-raf, BRAF-1, BRAF1, NS7, RAFB1}, Pdcd1 (programmed cell death 1) [NCBI Gene 18566] {aka Ly101, PD-1, Pdc1}, LIPC (lipase C, hepatic type) [NCBI Gene 3990] {aka HDLCQ12, HL, HTGL}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, RFC4 (replication factor C subunit 4) [NCBI Gene 5984] {aka A1, MRMNS, RFC37}, DEPDC1 (DEP domain containing 1) [NCBI Gene 55635] {aka DEP.8, DEPDC1-V2, DEPDC1A, SDP35}, CXCR6 (C-X-C motif chemokine receptor 6) [NCBI Gene 10663] {aka BONZO, CD186, CDw186, STRL33, TYMSTR}, Csf1r (colony stimulating factor 1 receptor) [NCBI Gene 12978] {aka CD115, CSF-1R, Csfmr, Fim-2, Fim2, Fms}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, Cd68 (CD68 antigen) [NCBI Gene 12514] {aka Lamp4, Scard1, gp110}, KCNIP3 (potassium voltage-gated channel interacting protein 3) [NCBI Gene 30818] {aka CSEN, DREAM, KCHIP3}, CD68 (CD68 molecule) [NCBI Gene 968] {aka GP110, LAMP4, SCARD1}, VCAM1 (vascular cell adhesion molecule 1) [NCBI Gene 7412] {aka CD106, INCAM-100}, CD163 (CD163 molecule) [NCBI Gene 9332] {aka M130, MM130, SCARI1}, ADGRE1 (adhesion G protein-coupled receptor E1) [NCBI Gene 2015] {aka EMR1, TM7LN3}, NOS2 (nitric oxide synthase 2) [NCBI Gene 4843] {aka HEP-NOS, INOS, NOS, NOS2A}, PTGS2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 5743] {aka COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2}, Braf (B-Raf proto-oncogene, serine/threonine kinase) [NCBI Gene 109880] {aka 9930012E13Rik, B-raf, Braf-2, Braf2, C230098H17, D6Ertd631e}, BRIP1 (BRCA1 interacting DNA helicase 1) [NCBI Gene 83990] {aka BACH1, FANCJ, OF}, CSF1R (colony stimulating factor 1 receptor) [NCBI Gene 1436] {aka BANDDOS, C-FMS, CD115, CSF-1R, CSFR, FIM2}
- **Diseases:** OS (MESH:D011475), Ulceration (MESH:D014456), colorectal cancers (MESH:D015179), Melanoma (MESH:D008545), lung cancer (MESH:D008175), metastasis (MESH:D009362), ovarian cancer (MESH:D010051), inflammation (MESH:D007249), gastric cancer (MESH:D013274), pancreatic ductal adenocarcinoma (MESH:D021441), Tumour (MESH:D009369),  (MESH:D012878),  (MESH:D018450)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** BRAFV600E

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC7653046/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC7653046/full.md

## References

44 references — full list in the complete paper: https://tomesphere.com/paper/PMC7653046/full.md

---
Source: https://tomesphere.com/paper/PMC7653046